Trending Topics

 
 
  • Is Sirolimus the Superior Heart Transplant Antirejection Therapy?   With 20 years of experience with sirolimus, two Mayo Clinic experts describe the advantages and disadvantages of this antiproliferative drug in patients after heart transplant.
  • Paclitaxel-Coated Devices on Pause for Patients With PAD   Why has Mayo Clinic placed a temporary moratorium on paclitaxel-coated devices for PAD? Radiology and cardiology experts discuss the controversy and what it will take to settle the issue.
  • Are e-Cigarettes Safer Than Tobacco? It's Complicated   Do e-cigarettes help people quit smoking tobacco? Maybe, but they come with risks, say Mayo Clinic experts.
  • Entering the TWILIGHT Zone of DAPT Duration   Experts from the Mayo Clinic discuss the impact of TWILIGHT, a comparison of ticagrelor monotherapy vs dual-antiplatelet therapy in post-PCI patients.
  • Virtual Reality in Medicine: Beyond Bulky Goggles   A trainee can stand in the surgeon's place instead of straining to see what's going on -- just one of the possibilities of virtual and immersive technologies in medicine, according to Mayo 's Dr Suraj Kapa.
  • The Lowdown on Lipoprotein(a)   Drs Tom Allison and Stephen Kopecky discuss current understanding of this unique subclass of lipoprotein and how to address elevated levels.
  • ISCHEMIA: Do Baseline Data Hint at Triumph for OMT?   The success of OMT and the decline of patients with severe ischemia may make it difficult for ISCHEMIA to show benefit for revascularization, predicts Mayo Clinic's Raymond Gibbons, MD.
  • Noninvasive Imaging for Suspected CAD: Which Test When?   Dr Anavekar explains the pros and cons of current noninvasive imaging modalities and his preferences for inpatient and outpatient assessment of CAD.
  • Today's Cardiac Intensive Care Unit--Not Your Mother's CCU   Cardiac intensive care units have evolved rapidly in recent years. Drs Barsness and Acharya discuss unique training and resource requirements for a model CICU.
  • Sleep Apnea and Cardiovascular Disease   Dr Virend Somers sits down with Dr Jay Widmer to parse the relationships between central and obstructive sleep apnea and cardiovascular diseases--and the best treatment strategies for each.
  • The Scoop on the New Syncope Guidelines   Drs Win-Kuang Shen and Peter Noseworthy discuss key recommendations on the diagnosis and management of syncope as published in the new ACC/AHA guidelines.
  • Robotic-Assisted PCI: Time to Jump to the Joystick?   Drs Gayatri Acharya and Sandhu discuss the current data for robotic-assisted PCI and whether it's ready for prime time.
  • Debunking Five Myths in Peripheral Arterial Disease   Drs Leslie Cooper and Amy Pollak debunk misconceptions on the diagnosis and treatment of PAD.
  • New Leads on Leadless Pacemakers and SubQ ICDs   Drs Jeffrey Geske and Paul Friedman discuss new devices for managing arrhythmias, including leadless pacemakers and subcutaneous defibrillators.
  • Stress, the Heart, and the Sexes   The differing biological and social bases for how men and women perceive and respond to stress should inform stress management approaches for better heart health, says Dr Anjali Bhagra.
  • Cardio-Oncology: An Integrative Approach   Dr Naveen L Pereira talks to Dr Joerg Herrmann about the importance of bringing cardiology and oncology together and his hopes for the future for the new cardio-oncology clinic.
  • The Molecular Autopsy in Evaluating Sudden Death   Dr Frank Cetta sits down with Dr Michael Ackerman to talk about the challenges in using postmortem genetic testing to determine the cause of unexplained sudden death.
  • Back-to-School Athletic Screening: Yea or Nay?   Drs Ackerman and Cetta review the pros and cons of screening school-age athletes for risk of sudden cardiac death.
  • Cardiac Critical Care: Limiting Unnecessary Treatment   Dr Sunil Mankad interviews Dr Gregory Barsness about Choosing Wisely when it comes to treating cardiac patients in the intensive care unit.
  • Making Decisions With, Not for, Patients   Selma Mohammed and Victor Montori explore the merits of shared decision making and highlight a tool to facilitate the discussion on whether to take a statin for primary prevention.